eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hepatitis c |
| Comorbidity | C0023895|liver disease |
| Sentences | 76 |
| PubMedID- 20616580 | Lipid metabolism and liver disease in hepatitis c viral infection. |
| PubMedID- 20617177 | Chronic hepatitis c is associated with severe liver disease including hepatitis, liver cirrhosis and hepatocellular carcinoma and it is the most frequent indication for liver transplantation [4]. |
| PubMedID- 22318146 | hepatitis c virus (hcv) leads to progressive liver disease and hepatocellular carcinoma. |
| PubMedID- 22457795 | It is known that most cases of hcc developed from a pre-existing chronic liver disease, usually due to hepatitis c virus, hepatitis b virus or alcohol. |
| PubMedID- 22087124 | Background: nonalcoholic fatty liver disease develops in patients with chronic hepatitis c. |
| PubMedID- 25088088 | Background and aim: assessment of the severity of liver disease following infection with hepatitis c virus (hcv) is important in treatment selection and prognosis. |
| PubMedID- 21258658 | Hepatitis b and hepatitis c are important causes of chronic liver disease globally. |
| PubMedID- 22419479 | We enrolled 184 hepatitis c-infected patients with chronic liver diseases or hcc, 57 healthy subjects and 27 hcc patients with other etiology. |
| PubMedID- 23707779 | Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis c: analysis of the hepatitis c antiviral long-term treatment against cirrhosis trial. |
| PubMedID- 20531062 | Objective: liver disease associated with hepatitis c virus (hcv) is a serious cause of mortality among people living with human immunodeficiency virus/acquired immunodeficiency syndrome (hiv/aids) (plwha). |
| PubMedID- 22160684 | In a significant portion of patients chronic hepatitis c infection leads to serious liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 22030902 | Risk for future clinical outcomes is proportional to the severity of liver disease in patients with chronic hepatitis c virus (hcv). |
| PubMedID- 21280186 | A 52-year-old man had end-stage liver disease due to hepatitis c and pphtn; the latter showed a suboptimal response to pulmonary vasodilator therapy with continuous intravenous treprostinil sodium and oral sildenafil citrate and was considered a contraindication to isolated lt. |
| PubMedID- 22797645 | Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy: a randomized controlled trial. |
| PubMedID- 19902246 | Antiviral therapy of chronic hepatitis c in patients with advanced liver disease and after liver transplantation. |
| PubMedID- 21849046 | In one of the studies, mmp-9 levels were negatively correlated to the histological severity of the liver disease in patients with chronic hepatitis c [63]. |
| PubMedID- 24130726 | This study analyses the evolution of liver disease in women with chronic hepatitis c during the third trimester of pregnancy and the post-partum period, as a natural model of immune modulation and reconstitution. |
| PubMedID- 22542039 | liver disease due to chronic hepatitis c is now a leading cause of mortality among hiv-infected patients in the developed world. |
| PubMedID- 22505377 | Background/aims: hepatitis c virus leads to chronic liver disease, cirrhosis and hepatocellular cancer. |
| PubMedID- 20104219 | Conclusions: measures of cognitive function were neither influenced by low-dose peginterferon treatment nor with objective evidence of liver disease progression in patients with advanced chronic hepatitis c prospectively followed up for 3.5 years. |
| PubMedID- 25616017 | Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis c. |
| PubMedID- 21294867 | The high proportion of patients with chronic liver disease associated with hepatitis c virus coinfection might have contributed to lessen the differences between treatment groups. |
| PubMedID- 21918437 | Management of end-stage liver disease in hiv/hepatitis c virus co-infection. |
| PubMedID- 24575168 | Conclusion: genetic mutations that cause inherited liver diseases in patients with hepatitis c should be studied in detail. |
| PubMedID- 23226395 | liver disease due to hepatitis c virus (hcv) infection is an important health problem worldwide. |
| PubMedID- 21031537 | Liver transplantation is currently the only definitive modality for the treatment of end-stage liver disease due to chronic hepatitis c. |
| PubMedID- 26138651 | Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression. |
| PubMedID- 21911884 | Conclusion: based on our data, microsatellite variations in the hmox1 and ugt1a1 genes are not likely to protect from progression of liver disease in patients with chronic hepatitis c. |
| PubMedID- 21029257 | Uptake of hepatitis c antibody testing in patients with end-stage liver disease in glasgow, 1993-2007. |
| PubMedID- 21743223 | She was suffering from end-stage liver disease due to hepatitis c virus (hcv) infection and renal disease due to diabetic nephropathy. |
| PubMedID- 21145859 | Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis c patients with minimal liver disease. |
| PubMedID- 23763386 | Aim: in chronic liver disease associated with hepatitis c virus (hcv), a low platelet count is a major obstacle in carrying out interferon (ifn) treatment. |
| PubMedID- 24695489 | End stage liver disease associated with hepatitis c virus infection constitutes one of the principal indications for liver transplant. |
| PubMedID- 22504920 | Hepatitis b and hepatitis c infections are important causes of end-stage liver disease and primary liver cancer. |
| PubMedID- 20388084 | Most cases of hcc develop on a pre-existing chronic liver disease, usually due to hepatitis c virus (hcv), hepatitis b virus (hbv), or alcohol. |
| PubMedID- 26444967 | Are anti-tnf-alpha agents safe for treating psoriasis in hepatitis c virus patients with advanced liver disease. |
| PubMedID- 21188525 | Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis c infection. |
| PubMedID- 25288416 | We found nationwide trends in increasing morbidity and medical costs for advanced liver disease associated with hepatitis c. |
| PubMedID- 25961570 | Reduced expression of ifnar1 has also been observed in the liver biopsies of chronic liver disease patients with hepatitis c virus infection [40]. |
| PubMedID- 19800334 | Background & aims: human immunodeficiency virus (hiv) infection accelerates liver disease progression in patients with hepatitis c virus (hcv) and could shorten survival of those awaiting liver transplants. |
| PubMedID- 21128862 | liver disease in patients with chronic hepatitis c virus (hcv) infection has an accelerated course in the presence of human immunodeficiency virus (hiv) coinfection. |
| PubMedID- 25848478 | However, chronic hepatitis c is associated with a higher liver disease related cardiovascular and all-cause mortality of hd patients. |
| PubMedID- 23796722 | Methods: two patients, who had already received a liver transplant (lt) in the past, with an end-stage liver disease due to recurrent hepatitis c virus cirrhosis, suffering acute-on-chronic liver failure while on the waiting list for an lt, received ht as a bridge to whole-organ retransplantation. |
| PubMedID- 25274075 | In haemophilia, acetaminophen often has limited efficacy at therapeutic doses, offering a narrow dosing range in those with liver disease due to chronic hepatitis c. |
| PubMedID- 22970270 | Eligible patients were ≥18 years of age, had compensated liver disease due to chronic hepatitis c virus (hcv) infection (any fibrosis stage, including compensated cirrhosis), detectable plasma hcv rna levels, and had received no previous treatment for hepatitis c. patients were excluded if they were co-infected with human immunodeficiency virus or hepatitis b virus or had any other cause of liver disease, severe depression or psychiatric disorder, or active substance or alcohol consumption >20 g/day in the last five years, as evaluated by a questionnaire. |
| PubMedID- 22619486 | Reported on 3 patients suffering from sp after liver transplantation, namely, two 42- and 62-year-old males with end-stage liver disease due to hepatitis c infection without significant other past medical or surgical history and a 59-year-old alcoholic. |
| PubMedID- 24516785 | Abstract: hepatitis c virus infection leads to liver disease whose severity can range from mild to serious lifelong illness. |
| PubMedID- 25716364 | Functional and morphological myocardial changes in hepatitis c virus patients with end-stage liver disease. |
| PubMedID- 20678018 | End-stage liver disease due to hepatitis c virus infection (hcv) is the principal indication for liver transplantation. |
| PubMedID- 25805611 | A 51 years old male patient with end stage liver disease due to chronic hepatitis c virus infection received a right hemi-liver graft from his brother. |
Page: 1 2